1606 Corp. (CBDW)
OTCMKTS
· Delayed Price · Currency is USD
0.0064
+0.0004 (7.02%)
May 9, 2025, 3:40 PM EDT
1606 Corp. Revenue
In the year 2024, 1606 Corp. had annual revenue of $7.20K with 348.85% growth.
Revenue
7.20K
Revenue Growth
+348.85%
P/S Ratio
122.18
Revenue / Employee
7.20K
Employees
1
Market Cap
879.11K
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cuisine Solutions | 80.48M |
Armanino Foods of Distinction | 69.40M |
ESG Inc. | 12.68M |
Huahui Education Group | 1.23M |
Crimson Wine Group | 72.99M |
Hongchang International | 2.87M |
Innovative Food Holdings | 72.13M |
Pyxus International | 2.38B |
1606 Corp. News
- 5 weeks ago - 1606 Corp. AI Chatbots Innovations, Strategic Partnerships, and 10-K Reporting Update - Accesswire
- 2 months ago - 1606 Corp. Signs LOI to Be Acquired by Private Group Seeking to Enter the Public Markets and Utilize AI Technologies for Potential Uplisting - Accesswire
- 3 months ago - 1606 Corp. Applauds RedChip's Launch of RedChat, Validating the Success and Impact of Our Own AI-Driven IRChat - Accesswire
- 3 months ago - GPOPlus+ Announces Strategic Partnership with 1606 Corp to Revolutionize AI-Powered Distribution Solutions for Gas Stations + Convenience Stores - Accesswire
- 3 months ago - 1606 Corp. Announces Strategic Partnership With GPOPlus to Enhance AI-Driven Distribution Solutions - Accesswire
- 3 months ago - DeepSeek's Lower Prices Will Enable 1606 Corp. to Offer More Affordable Solutions and Drive Industry Innovation - Accesswire
- 4 months ago - 1606 Corp. Applauds Adnexus Biotechnologies' Launch of Trapicolast: A Revolutionary New AI-Driven Malaria Drug - Accesswire
- 4 months ago - 1606 Corp. Applauds Adnexus Biotechnologies' Launch of Trapicolast: A Revolutionary New AI-Driven Malaria Drug - Accesswire